Ozasa, Ami <br/><br/>
Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells.  [electronic resource] 

 -  Bone  Jun 2005 
 - 1056-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>8756-3282 
<br/><br/><label>Standard No.: </label>10.1016/j.bone.2005.03.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Butadienes--pharmacology<br/>Cell Count<br/>Cell Differentiation<br/>Cell Line, Tumor<br/>Cell Size--drug effects<br/>Chondrocytes--drug effects<br/>Cyclic GMP--metabolism<br/>Fibroblast Growth Factor 2--pharmacology<br/>Fibroblast Growth Factors--pharmacology<br/>Flavonoids--pharmacology<br/>Gene Expression--drug effects<br/>Growth Plate--cytology<br/>Guanylate Cyclase--metabolism<br/>Humans<br/>MAP Kinase Signaling System--drug effects<br/>Mice<br/>Mice, Inbred ICR<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Mitogen-Activated Protein Kinase 3--metabolism<br/>Natriuretic Peptide, C-Type--pharmacology<br/>Nitriles--pharmacology<br/>Organ Culture Techniques<br/>Phosphorylation--drug effects<br/>Protein Kinase Inhibitors--pharmacology<br/>Rats<br/>Receptor, Fibroblast Growth Factor, Type 3--genetics<br/>Tibia--drug effects